A platform for analyzing immunology data
Official title: THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT)
NIH-11134470 · Data updated 2026-11-12
This study is working on making a helpful online tool called ImmPort even better, so researchers studying immune responses can easily collect, store, and share important health data to support their work in biodefense.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 30, 2022 |
| Project end | September 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $3,301,707 |
| NIH project number | 316201200036W-P00005-759302200001-1 |
| Project ID | NIH-11134470 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals involved in or affected by biodefense immunology studies, including researchers and healthcare professionals.
✕Less likely to help
Patients not involved in biodefense immunology research or those outside the scope of clinical data analysis may not benefit from this research.
What this research studies
This research focuses on enhancing a bioinformatics platform called ImmPort, which supports biodefense immunology research. It aims to improve methods for collecting, storing, and sharing clinical data, ensuring that researchers can access and analyze this information effectively. The project will also develop new tools for data integration and retrieval, providing technical support to users and optimizing the platform's usability for various research needs.
Why it matters
Potential benefit: If successful, this research could significantly improve the accessibility and analysis of immunology data, leading to better insights and advancements in biodefense strategies.
How similar studies have gone: Previous research has shown success in developing bioinformatics platforms for data analysis, indicating that this approach has potential for impactful outcomes.
Where this research is happening
Dulles, United States
Researchers
- Principal investigator: Butte, Atul
- Study coordinator: Butte, Atul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.